Texas Oncology-Sherman — Sherman, Texas

Texas Oncology-Sherman is a clinical research site located in Sherman, Texas, United States 75090.

Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.

Texas Oncology-Sherman has participated in 16 clinical trials with 2 currently active.

Therapeutic areas: Pancreatic Adenocarcinoma, Neoplasms, Cancer.

Sponsors: ImmunoGenesis, GRAIL, Inc., Eisai Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Sherman

Browse all research sites in Texas · View every site in Sherman

• Texas Cancer Center-Sherman
• Sherman Clinical Research
• Research Site
• Texas Institute for Neurological Disorders
• Texas Oncology, PA at Texas Cancer Center - Sherman
• Novartis Investigative Site
• GSK Investigational Site
• Texas Institute for Neurological Disorders - Sherman
• Revival Research Institute, LLC
• Clinical Trial Site
• Medrasa Clinical Research

Sponsor Feasibility Report

Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology-Sherman?

Texas Oncology-Sherman has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology-Sherman conducted?

Texas Oncology-Sherman has 16 clinical trials on record, with 2 currently active. Their work covers Pancreatic Adenocarcinoma, Neoplasms, Cancer.

Is Texas Oncology-Sherman accredited by Crixeo Clinical Trials?

Texas Oncology-Sherman has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology-Sherman?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.